Dr. Alexandra Vallon-Eberhard, Senior Director Global Business Development- Diagnostics Biomarkers and Digital Healthcare Solutions at Roche
Dr. Alexandra Vallon-Eberhard
Senior Director Global Diagnostics BD
Dr. Alexandra Vallon-Eberhard has over 15 years of extensive international business
development, investment, innovation and managerial experience. She is focusing her work
on personalized patient care and digital healthcare solutions, currently serving as Senior
Director Global Business Development – Diagnostics Biomarkers and Digital Healthcare
Solutions at Roche.
Alexandra successfully co-built the 2019 Frost & Sullivan awarded next-gen data platform
(Sequoia-backed) and supported over 40 of the fortune 500 companies in their
inorganic/venture growth strategy in the era of digital transformation. Over the past 10 years,
Alexandra has accompanied Israeli and Swiss start-ups in their financial, strategic and
Since 2020, she is a proud board member of the Weizmann Young European Network,
expert member of the digital health hub @Lausanne Biopole and volunteer of the Healthcare
Alexandra earned her PhD in Immunology/Virology at bioMerieux (France), her post-
doctorate at the Weizmann Institute of Science (Israel) and received six academic awards.
Alexandra also earned an International MBA from Bar Ilan University (Israel).